Company Overview

Ayr Wellness Inc. is a vertically integrated, multi-state cannabis operator engaged in the cultivation, manufacturing, and retail sale of cannabis products for medical and adult-use markets. The company operates within the regulated cannabis industry, focusing on plant-touching operations across multiple U.S. states. Its primary revenue drivers include branded cannabis flower, concentrates, vape products, and edibles sold through company-owned dispensaries and wholesale channels.

The company serves registered medical cannabis patients and adult-use consumers, depending on state regulatory frameworks, with a strategy centered on limited-license markets that offer higher barriers to entry. Ayr Wellness traces its origins to operations launched in 2017 and expanded rapidly through acquisitions and organic development. Over time, it evolved into a scaled multi-state operator with an emphasis on operational efficiency, cost discipline, and brand standardization across its footprint.

Business Operations

Ayr Wellness conducts operations through vertically integrated state-level subsidiaries, encompassing cultivation facilities, manufacturing assets, and retail dispensaries. The company generates revenue primarily from direct-to-consumer retail sales, supplemented by wholesale distribution to third-party dispensaries in certain markets. Core operating segments are aligned by state rather than product line, reflecting regulatory requirements in the cannabis industry.

The company controls indoor and greenhouse cultivation facilities, extraction and manufacturing labs, and branded retail stores operating under the AYR, Liberty Health Sciences, and other localized banners. Operations are primarily domestic within the United States, as U.S. federal law restricts interstate commerce and international plant-touching cannabis activities. Data on specific technology ownership beyond standard cultivation and processing systems is limited based on available public disclosures.

Strategic Position & Investments

Ayr Wellness’ strategic direction emphasizes profitability, balance sheet management, and optimization of existing assets rather than aggressive geographic expansion. Growth initiatives have included selective capital investments in cultivation efficiency, retail productivity, and brand development, as well as divestitures or restructuring in underperforming markets. The company has publicly prioritized cost reductions and cash flow generation amid broader industry pricing pressure.

Historically, Ayr Wellness expanded through acquisitions of state operators and retail portfolios, including the acquisition of Liberty Health Sciences and Origyn Extracts, which materially increased its scale and brand portfolio. The company maintains ownership of multiple state-licensed subsidiaries, though detailed disclosure of minority investments or joint ventures is limited. Public filings indicate ongoing evaluation of emerging product categories, but data on involvement in novel cannabis-adjacent technologies is inconclusive based on available public sources.

Geographic Footprint

Ayr Wellness operates exclusively in the United States, with licensed operations across multiple states primarily concentrated in the Northeast, Midwest, and Southeast regions. Its headquarters is located in Miami, Florida, which also represents one of its largest operational markets by store count and cultivation capacity.

The company maintains a multi-regional presence that includes established markets such as Florida, Massachusetts, Pennsylvania, Ohio, and New Jersey, among others. All operations are conducted within state borders in compliance with local regulations, and the company does not report international cultivation or retail activities due to federal legal constraints.

Leadership & Governance

Ayr Wellness is led by an executive team with experience in consumer packaged goods, regulated industries, and cannabis operations. Leadership has emphasized disciplined capital allocation, regulatory compliance, and operational execution as core elements of the company’s governance approach. The board of directors includes independent members with backgrounds in finance, healthcare, and corporate strategy.

Key executives include:

• David Goubert – President & Chief Executive Officer
• Amitay Luria – Chief Financial Officer
• George DeNardo – Chief Operating Officer
• Paul Goral – Chief Legal Officer
• Sherry Bunting – Chief Human Resources Officer